홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Deferoxamine → 3,4-Diacetoxy-1-butene

HRID 2393487
인쇄

반응식

HRID 2393487 반응식
N[C@H](C(N1C(=O)N[C@H]2[C@@H]1CS[C@H]2C[CH2:13][CH2:14][CH2:15][C:16](=[O:18])O)=O)CS.[CH3:23][C:24](N(O)CCCCCNC(CCC(N(O)CCCCCNC(CCC(N(O)CCCCCN)=O)=O)=O)=O)=[O:25].CS(O)(=O)=O.[OH-].[Na+].C1C(=O)N([O:76][C:77]([CH2:79]I)=[O:78])C(=O)C1.CC(N(O)CCCCCNC(CCC(N(O)CCCCCNC(CCC(N(O)CCCCCN)=O)=O)=O)=O)=O>CO>[CH3:23][C:24]([O:13][CH2:14][CH:15]([O:78][C:77]([CH3:79])=[O:76])[CH:16]=[CH2:18])=[O:25]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 5

HCID 2973DeferoxamineHCID 14798Sodium Hydroxide2회HCID 62881Deferoxamine MesylateHCID 3299230Iodoacetic acid N-hydroxysuccinimide esterHCID 131720825N-cysteinyl-biotin

생성물 1

HCID 27350013,4-Diacetoxy-1-butene

시약·촉매·용매 1

HCID 887Methanol용매

실험 절차

DACB was synthesized by covalently conjugating iodoacetyl-deferoxamine and N-cysteinyl-biotin by the following Scheme II. ##STR20## Solid deferoxamine mesylate was added to methanol for a concentration of 20 mM, followed by addition of NaOH to reach a final concentration of 20 mM NaOH. The solution was heated and maintained at 65°. Solid iodoacetic acid N-hydroxysuccinimide ester (NHS-IA) was added to the deferoxamine solution to a final molarity of 50mM NHS-IA and incubated for at least one hour at 65°. The resulting iodoacetyl-deferoxamine (IA-DFO) was purified by HPLC with an EM LiChroCART reverse phase column using a linear gradient of 0-10 ml 100% Buffer A (0.025M phosphate, pH 6, 2 mM NTA) and 10-60 ml 0-100% Buffer B (0.025M phosphate, pH 6, 2 mM NTA, 75% methanol). IA-DFO, but not unconjugated DFO, has an absorbance at 260 nm and thus was purified by measuring the absorbance of the eluate and collecting the fraction with absorbance at 260 nm.

후처리

  1. temperatureThe solution was heated
  2. temperaturemaintained at 65°
  3. waitincubated for at least one hour at 65°
  4. customThe resulting iodoacetyl-deferoxamine (IA-DFO) was purified by HPLC with an EM LiChroCART reverse phase column
  5. customthus was purified
  6. customcollecting the fraction with absorbance at 260 nm

출처 및 근거

ORD 기록
ord-51bebd3a49be48da8d6c3ecbb677d478
출처 데이터셋
uspto-grants-1998_09
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US05807879

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트